FIELD: chemistry.
SUBSTANCE: invention relates to biochemistry, particularly to an antibody-drug conjugate for treating and preventing cancer. Disclosed are a compound which is used to produce said conjugate; pharmaceutical composition containing said conjugate. Also disclosed is a method of treating a tumour using said conjugate.
EFFECT: invention makes it possible to effectively treat cancer.
66 cl, 2 tbl, 49 dwg, 154 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ZINC FINGER PROTEIN 2 (IKZF2) OF THE IKAROS FAMILY | 2019 |
|
RU2797559C2 |
| ANTIBODY TO B7H3-EXATECAN ANALOGUE CONJUGATE AND ITS USE IN MEDICINE | 2019 |
|
RU2785664C2 |
| ANTIBODY-DRUG CONJUGATE, INTERMEDIATE FOR ITS PRODUCTION, METHOD OF ITS PRODUCTION AND ITS USE | 2020 |
|
RU2800137C1 |
| MAITANZINOID DERIVATIVES WITH SELF-SPLITTING PEPTIDE LINKERS AND THEIR CONJUGATES | 2018 |
|
RU2765098C2 |
| DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS SUITABLE AS KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES | 2018 |
|
RU2804468C2 |
| ANTIBODY-DRUG CONJUGATE | 2013 |
|
RU2776489C2 |
| NEW CYCLIC DINUCLEOTIDE DERIVATIVE AND ITS ANTIBODY-DRUG CONJUGATE | 2019 |
|
RU2809547C2 |
| CONJUGATE OF ANTI-CLAUDIN ANTIBODY AND MEDICINAL AGENT AND PHARMACEUTICAL USE THEREOF | 2020 |
|
RU2826119C1 |
| ANTIBODIES TO B7-H3 AND CONJUGATES OF ANTIBODY AND DRUG | 2017 |
|
RU2764651C2 |
| ANTI-HER3 CONJUGATE ANTIBODY-DRUG | 2015 |
|
RU2802211C2 |
